COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Announces Third Quarter 2025 Financial Results
28/11/2025
WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its third quarter 2025 financial results. Third Quarter 2025 Financial [...]
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
28/11/2025
SKYRIZI ® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s disease (CD) and now [...]
L’Agence des médicaments du Canada émet une recommandation positive pour le remboursement de SKYRIZI® (risankizumab) pour le traitement de la colite ulcéreuse, et AbbVie conclut une lettre d’intention avec l’Alliance pharmaceutique pancanadienne
28/11/2025
SKYRIZI ® , un inhibiteur de l’interleukine 23 (IL-23), a fait l’objet de deux recommandations consécutives de l’Agence des médicaments du Canada (AMC) visant son remboursement pour le traitement des maladies [...]
Shriners Hospitals for Children Canada and Children’s Hospital at LHSC launch landmark research program to advance care in rare childhood bone disorders
28/11/2025
One-year anniversary of affiliation marked by national expansion in research and care for kids with complex conditions MONTREAL and LONDON, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- One year after announcing a [...]
Les Hôpitaux Shriners pour enfants Canada et l’Hôpital pour enfants du Centre des sciences de la santé de London lancent un programme de recherche historique pour faire progresser les soins liés aux maladies osseuses rares chez l’enfant
28/11/2025
Le premier anniversaire de l’affiliation des deux institutions est marqué par une expansion nationale de la recherche et des soins pour les enfants ayant des maladies complexes MONTRÉAL et LONDON, Ontario, 28 nov. 2025 [...]
Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
28/11/2025
Daix (France), New York City (New York, United States), November 28, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral [...]
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025
28/11/2025
Daix (France), New York City (New York, Etats-Unis), le 28 novembre 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer
28/11/2025
Oslo, Norway, 28 November 2025 – Zelluna (OSE: ZLNA ), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of cancer, today announced the [...]
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
28/11/2025
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
28/11/2025
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease TOKYO and CAMBRIDGE, Mass., Nov [...]
HealthTab™ to Power NHS Pilot
27/11/2025
Bringing Cholesterol-Lowering Injections to U.K. Community Pharmacies VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) is pleased to [...]
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
27/11/2025
Nyxoah to Participate in the Piper Sandler 37 th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “ [...]
Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference
27/11/2025
Nyxoah Participera à la Piper Sandler 37 th Annual Healthcare Conference Mont-Saint-Guibert, Belgique – 27 novembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société [...]
Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs
27/11/2025
The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer Active Pharmaceutical Ingredients manufacturing process MILAN, Nov. 27, 2025 [...]
GENFIT Announces Appointment of new Chief Medical Officer
27/11/2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
GENFIT annonce la nomination d’un nouveau Directeur Médical
27/11/2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 27 novembre 2025 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
27/11/2025
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism underscores commitment to women’s health and lifecycle transitions CDU [...]
Report finds adoption of barcoding system in Canadian healthcare can save billions annually while supporting patient safety
27/11/2025
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared by Deloitte Canada and commissioned by GS1 Canada finds that the lack of nationwide adoption of global standards via Global Trade Item Numbers (GTINs) and [...]
Un rapport conclut que l’adoption d’un système de codes à barres par le système canadien de soins de santé permettrait d’économiser des milliards chaque année tout en améliorant la sécurité des patients
27/11/2025
TORONTO, 27 nov. 2025 (GLOBE NEWSWIRE) -- Selon un nouveau rapport de Deloitte Canada demandé par GS1 Canada, l’absence d’adoption de normes internationales au Canada, telles que les codes articles internationaux (« [...]

Pages